申请人:Mjalli M. M. Adnan
公开号:US20060276518A1
公开(公告)日:2006-12-07
This invention provides certain compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of the invention are useful as antagonists, or more preferably, partial antagonist of factor IX and thus, may be used to inhibit the intrinsic pathway of blood coagulation. The compounds are useful in a variety of applications including the management, treatment and/or control of diseases caused in part by the intrinsic clotting pathway utilizing factor IX. Such diseases or disease states include stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures, long periods of confinement, and acquired or inherited pro-coagulant states.
本发明提供了某些化合物、它们的制备方法、包含这些化合物的制药组合物,以及它们在治疗人类或动物疾病中的应用。本发明的化合物可用作因子IX的拮抗剂,或更倾向于部分拮抗剂,因此可用于抑制血液凝固的内在途径。这些化合物可用于多种应用,包括通过利用因子IX的内在凝血途径引起的疾病的管理、治疗和/或控制。这些疾病或疾病状态包括中风、心肌梗塞、动脉瘤手术、手术过程中的深静脉血栓形成、长时间禁闭和获得性或遗传性促凝状态。